ClinicalTrials.Veeva

Menu

A Study of Aripiprazole in Patients With Schizophrenia in General Psychiatric Practices

Otsuka logo

Otsuka

Status and phase

Completed
Phase 3

Conditions

Schizophrenia and Schizoaffective Disorder

Treatments

Drug: Aripiprazole

Study type

Interventional

Funder types

Industry

Identifiers

NCT00292409
CN138-125

Details and patient eligibility

About

The purpose of this clinical research study is to evaluate the overall effectiveness of 8 week of aripiprazole treatment.

Enrollment

400 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • diagnosis of schizophrenia or schizoaffective disorder being treated as outpatients,no response to past antipsychotic treatment and patients who symptoms are notoptimally controlled defined as CGI- S<7

Exclusion criteria

  • pregnant or breastfeeding,patients at risk for committing suicide,diagnosis of mood disorders, delirium, dementia and other cognitive disorders,patients treatment resistant to otherantipyschotic medications and treatment with a long acting psychotic in which the last dose was within 3 months of treatment phase

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems